Sort
11,323 grants matching “glioblastoma”
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tu
$235,894Kevin Aaron Roth · University Of Alabama At Birmingham · R01 · FY2011 · CA
Lactate Transport as a Therapeutic Target in Glioma
$235,804Saroj Priyantha Mathupala · Wayne State University · R01 · FY2006 · CA
Electrical spectral imaging using magnetic resonance methods
$235,723Rosalind J Sadleir · Arizona State University-Tempe Campus · R21 · FY2022 · EB
Novel mouse models using MADR-GESTALT technology to accelerate glioma research
$235,632Linda M Liau · University Of California Los Angeles · P50 · FY2023 · CA
Incorporation of Novel MADR-GESTALT Technology into UCLA SPORE in Brain Cancer
$235,632Linda M Liau · University Of California Los Angeles · P50 · FY2023 · CA
MicroPET and NIR Fluorescence Imaging Tumor Angiogenesis
$235,614Stanford University · R21 · FY2004 · EB
NK Innate Immunity and Oncolytic Virus Therapy
$235,606Michael A Caligiuri · Ohio State University · P01 · FY2014 · CA
Molecular Mechanisms of SPARC Mediated Glioma Invasion
$235,517Jeremy N Rich · Duke University · R01 · FY2008 · NS
Uncovering Cross-Disease Platelet Transcriptomic Signatures to Advance Precision Medicine
$235,500Anandi Krishnan · Rutgers, The State Univ Of N.J. · R21 · FY2025 · HL
Neuroimmunology of Vaccines in Adoptive T-cell Therapy for Brain Tumor
$235,500John H Sampson · Duke University · R21 · FY2010 · NS
Pre-clinical Translation of Regulatory T-cell Inhibition in Brain Tumors
$235,500John H Sampson · Duke University · R21 · FY2010 · NS
GLIAL FILAMENT ASSOCIATED PROTEINS IN HUMAN ASTROCYTOMAS
$235,397Omar Skalli · Louisiana State Univ Hsc Shreveport · R01 · FY2006 · NS
SCH52365: PHASE I STUDY OF CYCLIC ORAL ADMINISTRATION
$234,837University Of Texas Hlth Sci Ctr San Ant · M01 · FY2001 · RR
SCH52365: PHASE I STUDY OF CYCLIC ORAL ADMINISTRATION
$234,837University Of Texas Hlth Sci Ctr San Ant · M01 · FY2002 · RR
SCH52365: PHASE I STUDY OF CYCLIC ORAL ADMINISTRATION
$234,837University Of Texas Hlth Sci Ctr San Ant · M01 · FY2002 · RR
glioma Through Genomics and Transgenic Mouse Model
$234,808Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
MET kinase fusions in pediatric glioblastoma
$234,750Renee D Read · Emory University · R21 · FY2022 · NS
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
$234,722Michael E. Berens · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA
SPORE: Targeted Therapies for Glioma
$234,721Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA
Regulatory T Cells and Oncolytic Virotherapy of Glioma
$234,684Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2015 · CA
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$234,589George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · CA
Lactate Transport as a Therapeutic Target in Glioma
$234,585Saroj Priyantha Mathupala · Wayne State University · R01 · FY2010 · CA
Lactate Transport as a Therapeutic Target in Glioma
$234,556Saroj Priyantha Mathupala · Wayne State University · R01 · FY2009 · CA
Analysis of active and inactive EGFR conformations
$234,554Kathryn M Ferguson · University Of Pennsylvania · R01 · FY2011 · CA
Analysis of active and inactive EGFR conformations
$234,554Kathryn M Ferguson · University Of Pennsylvania · R01 · FY2012 · CA